Philippe Armand obtained his MD and PhD (in Biomedical Sciences) from the University of California San Francisco. He completed a residency in Internal Medicine at Brigham and Women’s Hospital in 2004, and a fellowship in Hematology/Oncology at Dana-Farber Cancer Institute (DFCI) in 2007. Since then, he has worked in the Stem Cell Transplantation and Lymphoma Divisions at DFCI. He is currently a Professor of Medicine at Harvard Medical School, an Institute Physician at DFCI, the Harold and Virginia Lash/David Lash Chair in Lymphoma Research, and the Chief of the Division of Lymphoma. His clinical practice is solely focused on patients with lymphoma. His research interests center on the development of novel therapeutics and assays in lymphoma, with a key focus on the translation of local laboratory research to novel clinical trials. He actively mentors many junior investigators, both fellows and junior faculty, in both clinical care and clinical research.
Philippe Armand MD, PhD
Dana-Farber Cancer Institute
Boston, Massachusetts
United States
Project Title
Bispecific antibody-based frontline therapy for follicular lymphoma
Program
Academic Clinical Trials Program (ACT)